| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $17.0M | — | -39.3% |
| R&D Expense | $122.0M | — | +0.0% |
| SG&A Expense | $29.0M | — | +3.6% |
| Operating Income | -$134.0M | — | -9.8% |
| Interest Expense | $3.0M | — | +50.0% |
| Pre-tax Income | -$128.0M | — | -14.3% |
| Income Tax | $0 | — | — |
| Net Income | -$128.0M | — | -14.3% |
| EPS (Basic) | -$1.02 | — | +10.5% |
| EPS (Diluted) | -$1.02 | — | +10.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $201.0M | -9.5% | +4.7% |
| Current Assets | $844.0M | -16.2% | -18.1% |
| Total Assets | $997.0M | -12.5% | -13.8% |
| Current Liabilities | $209.0M | -9.5% | +8.9% |
| Long-term Debt | $100.0M | +1.0% | +108.3% |
| Stockholders' Equity | $524.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$138.0M | — | -4.5% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $114.0M | — | +256.3% |
| Financing Cash Flow | $3.0M | — | -97.9% |
| Free Cash Flow | -$138.0M | — | -3.8% |
| -1.3% |